National Heart Hospital

Sofia, Bulgaria
Сърдечна болница в София

About National Heart Hospital


Националната кардиологична болница е многопрофилна болница за активно лечение в София. Тя е университетска болница – част от структурата на Софийския медицински университет. МБАЛ „НКБ“ е единствената болница в България с отделения за детска кардиология и детска кардиохирургия.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Actelion
3
EMD Serono Research & Development Institute, Inc.
1
Idorsia Pharmaceuticals Ltd.
1
KU Leuven
1
Terumo Europe N.V.
1
University National Heart Hospital
1
Total Rows: 6

Clinical Trials at National Heart Hospital


During the past decade, National Heart Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years220011110000Started TrialsCompleted Trails2019202020210123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Oral Cladribine in Early Multiple Sclerosis (MS)
2008-12-31
2012-04-30
Completed
617
FFR vs. icECG in Coronary Bifurcations
2012-09-01
2020-12-01
Unknown status
37
Clinical Study to Assess the Long-term Safety, Tolerability, and Efficacy of Macitentan in Subjects With Eisenmenger Syndrome
2013-09-10
2018-01-12
Terminated
217
Clinical Study to Evaluate the Effects of Macitentan on Exercise Capacity in Subjects With Eisenmenger Syndrome
2013-05-21
2016-12-01
Completed
226
Prospective, Single-arm, Multi Centre Observations Ultimaster Des Registry
2014-06-01
2020-06-01
Unknown status
37,000
Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)
2019-07-29
2024-09-24
Active, not recruiting
187
Assessment of Patterns of Patient Reported Outcomes in Adults With Congenital Heart Disease - International Study II
2019-08-01
2022-11-30
Completed
8,167
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction
2021-08-14
2025-08-01
Enrolling by invitation
14,000

Rows per page:

1–8 of 8

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "National Heart Hospital" #1 sponsor was "Actelion" with 3 trials, followed by "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored, "Idorsia Pharmaceuticals Ltd." with 1 trials sponsored, "KU Leuven" with 1 trials sponsored and "Terumo Europe N.V." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.
Created with Highcharts 11.1.0Top Leading SponsorsActelion: 3Actelion: 3EMD Serono Research &Development Institute,Inc.: 1EMD Serono Research &Development Institute,Inc.: 1Idorsia Pharmaceuticals Ltd.: 1Idorsia Pharmaceuticals Ltd.: 1KU Leuven: 1KU Leuven: 1Terumo Europe N.V.: 1Terumo Europe N.V.: 1University NationalHeart Hospital: 1University NationalHeart Hospital: 1

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at National Heart Hospital


According to Clinical.Site data, the most researched conditions in "National Heart Hospital" are "Coronary Artery Disease" (2 trials), "Pulmonary Arterial Hypertension" (2 trials), "Acute Myocardial Infarction" (1 trials), "Congenital Heart Disease" (1 trials) and "Multiple Sclerosis" (1 trials). Many other conditions were trialed in "National Heart Hospital" in a lesser frequency.

Clinical Trials Intervention Types at National Heart Hospital


Most popular intervention types in "National Heart Hospital" are "Drug" (4 trials), "Combination Product" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Macitentan 10 mg" (2 trials), "Cladribine" (1 trials), "FDC macitentan/tadalafil" (1 trials) and "Intracoronary ECG" (1 trials). Other intervention names were less common.

Clinical Trials Genders at National Heart Hospital


The vast majority of trials in "National Heart Hospital" are 8 trials for "All" genders.

Clinical Trials Status at National Heart Hospital


Currently, there are NaN active trials in "National Heart Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in National Heart Hospital, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in National Heart Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 5Phase 3: 5

Created with Highcharts 11.1.0Trials StatusCompleted: 3Completed: 3Unknown status: 2Unknown status: 2Active, not recruiting: 1Active, not recruiting: 1Enrolling by invitation: 1Enrolling by invitation: 1Terminated: 1Terminated: 1

Departments of National Heart Hospital


National Heart Hospital has several departments that took part in Clinical trials: "MHAT National Cardiology Hospital EAD" - 16 trials
Departments List
Total Rows: 1